Tedmed Talk Changing The Drug Pricing Game From Ted Class Central As director of memorial sloan kettering hospital’s center for health policy and outcomes and the founder of the drug pricing lab, peter and his team strive to identify more rational approaches. Peter’s work is all about finding a balance between ensuring new and innovative drugs are developed and making sure they are not so expensive that people can’t afford them. he created the drugabacus, a first of its kind interactive tool that helps determine a fair price for a cancer drug based on its actual value to a patient.
Game Changing Competitive Pricing Strategy White Cup Trumprx and pbm reform are accelerating a shift in drug pricing. learn what this means for biopharma leaders, patients and global pricing strategy. The landscape of drug pricing in the united states is currently undergoing a period of significant and unprecedented change, marked by potentially transformative reforms. this blog post delves into the intricacies of several key initiatives that are reshaping the pharmaceutical industry. Drug pricing in 2026 is being reshaped at the pharmacy counter, in federal agencies and in courtrooms — all at once. Discover how to revolutionize drug pricing in this thought provoking ted talk. explore the challenges of high prescription drug costs in the united states and their impact on accessibility for those in need.
Game Changing Pricing And Promotions Innovations For The Decade Ahead Drug pricing in 2026 is being reshaped at the pharmacy counter, in federal agencies and in courtrooms — all at once. Discover how to revolutionize drug pricing in this thought provoking ted talk. explore the challenges of high prescription drug costs in the united states and their impact on accessibility for those in need. Policies that target both exorbitant prices of drugs and reduce out of pocket spending for patients must extend beyond medicare. drug pricing should reward scientific innovation, not gaming of the patent system. All odds are against patients in a drug pricing system characterized by profit driven pbms, health insurers and drug manufacturers. explore the ways the odds are stacked against patients. In this article, we explore how companies use models like nash equilibrium and bertrand competition to tackle some of the biggest challenges in drug pricing. During peter's ted talk presentation, he talked about how he wants to change the game with three rules: drugs should have a single price for each of their uses in the u.s., limit the roles of middleman and pharmacy benefit managers, and the prices of drugs should be tied in a fair way to their actual value.
Comments are closed.